Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |